UM: Stem Cell Research

By

The Detroit News reports on University of Michigan stem cell research that holds promise for people with amyotrophic lateral sclerosis (ALS), more commonly known as Lou Gehrig’s disease. The article quotes Eva Feldman, a UM professor and neurologist who’s leading a clinical trial using stem cells to treat patients: “I am extremely hopeful that we have found a way early in the course of the disease to make a true difference. Any treatment that can slow the progression of the disease is truly a home run for Lou Gehrig.” [Source]